Psilocybin reduces symptoms of major depression: The Lancet

Published Date: 04 Mar 2023

A new study by Robin von Rotz and his team found that moderate doses of psilocybin for at least two weeks reduced symptoms of depression...

Read Full News

Latest News

Retaining APPs: Why One APP Won’t Leave Rheumatology

Clear expectations, mutual respect with physicians, and compensation models all play important roles in retaining advanced practice providers, a physician assistant says.

Pneumonia Tied to Noncommunicable Disease Risk in Adults

Hospitalization for community-acquired pneumonia is linked to an increased risk of developing multiple chronic noncommunicable diseases over 5 years in adults.

Is ‘Spring Fatigue’ Real? Sleep Study Questions It

In a nine-wave online survey of 418 adults over 18 months, researchers find fatigue levels do not fluctuate seasonally — only everyday activity fatigue falls as days lengthen.

Telemedicine Matches Clinic Visits in IIH Care

Remote consults using optical coherence tomography data show high agreement with traditional clinic evaluations for the management of patients with idiopathic intracranial hypertension.

When Medications May Contribute to Cognitive Decline

Medication-related cognitive impairment is common, mimics neurodegenerative disease, increases with polypharmacy, and may be prevented with regular cognitive assessment monitoring.

Access to Mental Health Support ‘Uneven’ for Young Canadians

The need for mental health support services is high in Canada, especially among youth, but many are unable to access the care they need in a timely manner.

Todays Updates

Novel Psychedelic Promising on Resistant Depression

An investigative inhaled formulation of the psychedelic mebufotenin is linked to significant improvements in depression symptoms compared to placebo, a phase 2b trial shows.

Biocomputer From Human Neurons Plays Doom, Raises Ethics

A biological computer using human neurons learns Doom within 1 week, highlighting rapid adaptive learning and potential advantages over traditional AI systems.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

The findings could fill a treatment gap for patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC) who also carry TP53 mutations.

EMA OKs Two Treatments for Small Cell Lung Cancer

Both drugs increase overall and progression-free survival.

Todays Updates

Novel Psychedelic Promising on Resistant Depression

An investigative inhaled formulation of the psychedelic mebufotenin is linked to significant improvements in depression symptoms compared to placebo, a phase 2b trial shows.

Biocomputer From Human Neurons Plays Doom, Raises Ethics

A biological computer using human neurons learns Doom within 1 week, highlighting rapid adaptive learning and potential advantages over traditional AI systems.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

The findings could fill a treatment gap for patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC) who also carry TP53 mutations.

EMA OKs Two Treatments for Small Cell Lung Cancer

Both drugs increase overall and progression-free survival.

Latest News

Clear expectations, mutual respect with physicians, and compensation models all play important roles in retaining advanced practice providers, a physician assistant says.

Hospitalization for community-acquired pneumonia is linked to an increased risk of developing multiple chronic noncommunicable diseases over 5 years in adults.

In a nine-wave online survey of 418 adults over 18 months, researchers find fatigue levels do not fluctuate seasonally — only everyday activity fatigue falls as days lengthen.

Remote consults using optical coherence tomography data show high agreement with traditional clinic evaluations for the management of patients with idiopathic intracranial hypertension.

Medication-related cognitive impairment is common, mimics neurodegenerative disease, increases with polypharmacy, and may be prevented with regular cognitive assessment monitoring.

The need for mental health support services is high in Canada, especially among youth, but many are unable to access the care they need in a timely manner.

News All Time

AHS Recommends Annual Migraine Screening for Girls and Women

A new recommendation from the American Headache Society calls for annual migraine screening as part of preventive care for girls and women — from adolescence through menopause.

Biologics Don’t Promote Respiratory Infections

Reassuring data support the safety of biologics as an option for asthma care.

Biologics, Phototherapy in Psoriasis: Cost-Benefit Compared

A simulated analysis in psoriasis highlights divergent patient and payer incentives and inconsistent coverage strategies behind barriers to phototherapy uptake.

Spirituality Linked to Lower Risk for Substance Misuse

Integrating spirituality into patient care might hold potential for substance use prevention and recovery, a new meta-analysis shows.

GSK Gets US FDA Approval for Expanded Use Of RSV Vaccine

British drugmaker GSK said on Friday the U.S. Food and Drug ⁠Administration has expanded the approved age range for its respiratory syncytial virus vaccine, ⁠Arexvy, to...

WHO Confirms 18 Attacks on Healthcare Sites in Iran

The World Health Organization said on Wednesday that it has verified 18 attacks on healthcare centers ⁠in Iran since the start of the U.S. and Israel war on Iran.

How Can First-Year Residents Avoid Clinical Errors?

Experts say that many early residency mistakes stem from structural factors such as workload, supervision, and training environment, rather than from individual performance.

Dry Powder Inhaler May Reduce COPD Exacerbations

In patients with COPD, starting the umeclidinium-vilanterol dry powder inhaler may lower the risk for exacerbations compared with starting glycopyrrolate-formoterol or tiotropium-olodaterol inhalers.

Add-On Vancomycin Taper May Reduce C difficile Recurrence

In patients with a first episode or first recurrence of Clostridioides difficile infection, adding a vancomycin taper after the standard 14-day course may delay or lower the risk for recurrence.

Donna Ockenden to Lead Review of Leeds Maternity Failures

An independent review will examine maternity and neonatal services at Leeds Teaching Hospitals after repeated safety failures.

Tylenol Use Among Women Dropped After Trump Tied It to Autism, Lancet Analysis Shows

Tylenol use among pregnant women fell after U.S. President Donald Trump linked autism to the over-the-counter pain relief medicine, according to an analysis of U.S....

Generic Flovent Approval Expands Options for Asthma

Glenmark Specialty SA has received the FDA’s approval for true generic fluticasone propionate.

ETI Shows Minimal Bone Health Impact in Cystic Fibrosis

Elexacaftor-tezacaftor-ivacaftor combination therapy shows no clinically meaningful improvement in bone health or calcium metabolism in patients with cystic fibrosis, a Danish study shows.

Hospitalists Get Creative to Find Time for Research

Sometimes that may mean carving out an hour here or there during the day and, sometimes, it may mean working on a day off.

Rethinking Osteoarthritis: Inflammation, Metabolism, Repair

Emerging regenerative and cell-based therapies promise cartilage repair, yet most are preclinical or limited by durability and safety — underscoring the need for rigorous stratification.

Jamaica to End Medical Cooperation Program With Cuba

Jamaica will end a medical cooperation program with Cuba, ⁠as the two governments were unable to agree on the terms ⁠for a new arrangement.

Recommended News For You

Papillary thyroid cancer: New markers offer hope for tailored treatment

Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxis

Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL

Cancer "Tidal Wave" Prediction: Not Cigarette-Based, Either! Wary Stories Regarding Cannabis and Cancer.

How a California Oncologist Making $850k Spends Money

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit

Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL

Recommended Articles For You

Mastering Modern Oncology: Accreditation, Education, and Research Trends for 2025 

An Analytical and Statistical Journey through Genomic Revolution, Novel Therapeutics, and Future Horizons in Lymphoma 2025 

The benefits and risks of taking fludrocortisone for adrenal insufficiency  

HPV Infection Review: Epidemiology, Risks, and Therapeutic Advances for Clinicians 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Adjuvant ICIs: A Winner and a Loser in Clear Cell Renal Cell Carcinoma?

2.

The risk of ovarian cancer is not increased by salpingectomy, according to JAMA.

3.

Investigating the Relationship Between GERD and Anxiety/Depression.

4.

Chronic stress and obesity work together to accelerate pancreatic cancer development and growth, study finds

5.

FDA Leaders Explain Their Choice Regarding Cancer Risk Warning in CAR-T Investigation.

1.

Understanding Axitinib: What You Need To Know For Your Treatment Plan

2.

All You Need To Know About Partial Thromboplastin Time (PTT) Test

3.

Unveiling Canine Blood Clots Over Time: A Look at Low-Field MRI's Diagnostic Potential

4.

Screening Strategies in Oncology: A Subspecialty Guide to Early Detection and Better Outcomes

5.

Polyposis Syndrome: Causes, Symptoms, and Treatment Options

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

3.

Navigating the Complexities of Ph Negative ALL - Part XI

4.

Updates on the First Line Management of ALK+ NSCLC

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot